1
|
Roman G, Duthely LM, Attia J, Spike AE, McIntosh S, Pusek SN, Mehta DH, Bredella MA. Implementation and Evaluation of a National Well-Being Curriculum for KL2 Scholars. J Integr Complement Med 2024. [PMID: 38498028 DOI: 10.1089/jicm.2023.0701] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2024]
Abstract
Introduction: The study aimed to pilot test a well-being curriculum for KL2 scholars to be used across the Clinical and Translational Science Award consortium. Methods: Between November 2022, and May 2023, 36 KL2 scholars from 25 hubs participated in the program. The General Well-Being Index for U.S. Workers and the Patient Reported Outcomes Measurement Information System (PROMIS-29) were completed by scholars before and after the program. Results: Postparticipation, there was a trend of improvement in the domains of well-being, sleep, anxiety, and fatigue. Conclusion: Implementing a virtual synchronous well-being curriculum allowed the scholars to connect across the consortium and improve their well-being.
Collapse
Affiliation(s)
- Gretchen Roman
- Department of Family Medicine, University of Rochester Medical Center, Rochester, NY, USA
| | - Lunthita M Duthely
- Department of Obstetrics, Gynecology and Reproductive Sciences, University of Miami School of Medicine, Miami, FL, USA
- Department of Public Health Sciences, University of Miami School of Medicine, Miami, FL, USA
| | - Jacqueline Attia
- University of Rochester Center for Leading Innovation and Collaboration (CLIC), the CTSA Coordinating Center, University of Rochester Medical Center, Rochester, NY, USA
| | - Abby E Spike
- University of Rochester Center for Leading Innovation and Collaboration (CLIC), the CTSA Coordinating Center, University of Rochester Medical Center, Rochester, NY, USA
| | - Scott McIntosh
- University of Rochester Center for Leading Innovation and Collaboration (CLIC), the CTSA Coordinating Center, University of Rochester Medical Center, Rochester, NY, USA
| | - Susan N Pusek
- North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - Darshan H Mehta
- Center for Faculty Development and Benson-Henry Institute for Mind Body Medicine, Massachusetts General Hospital, Boston, MA, USA
| | - Miriam A Bredella
- Harvard Catalyst, The Harvard Clinical and Translational Science Center, Harvard Medical School, Boston, MA, USA
- Massachusetts General Hospital, Boston, MA, USA
- NYU Langone Health and Grossman School of Medicine, New York, NY, USA
| |
Collapse
|
2
|
Duong J, McIntosh S, Attia J, Michener JL, Cottler LB, Aguilar-Gaxiola SA. Attitudes towards diversity, equity, and inclusion across the CTSA Programs: Strong but not uniform support and commitment. J Clin Transl Sci 2023; 7:e66. [PMID: 37008605 PMCID: PMC10052433 DOI: 10.1017/cts.2022.525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Revised: 12/01/2022] [Accepted: 12/08/2022] [Indexed: 02/10/2023] Open
Abstract
Background This study describes attitudes towards diversity, equity, and inclusion (DEI) among members of the Clinical and Translational Science Awards (CTSA) Program. It also explores associations between program members' roles and their perceived importance of and commitment to improving DEI and assesses the link between perceived importance of and commitment to improving DEI. Lastly, it ascertains barriers and priorities concerning health equity research, workforce development, CTSA consortium leadership, and clinical trials participation among respondents. Methods A survey was administered to registrants of the virtual CTSA Program 2020 Fall Meeting. Respondents reported their roles, perceived importance of and commitment to improving DEI. Bivariate cross-tabulations and structural equation modeling examined associations between respondents' roles, perceived importance of DEI, and commitment to improving DEI. Grounded theory was used to code and analyze open-ended questions. Results Among 796 registrants, 231 individuals completed the survey. DEI was "extremely important" among 72.7 percent of respondents and lowest among UL1 PIs (66.7%). Being "extremely committed" to improving DEI was reported by 56.3 percent of respondents and lowest among "other staff" (49.6%). Perceived importance of DEI was positively associated with commitment to improve DEI. Institutional and CTSA Commitment, Support, and Prioritization of DEI represented a key theme for improving DEI among respondents. Conclusion Clinical and translational science organizations must take bold steps to transform individual perceptions of DEI into commitment and commitment into action. Institutions must set visionary objectives spanning leadership, training, research, and clinical trials research to meet the promise and benefits of a diverse NIH-supported workforce.
Collapse
Affiliation(s)
- Jeffrey Duong
- Center for Reducing Health Disparities, University of California – Davis School of Medicine, Sacramento, CA, USA
| | - Scott McIntosh
- Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
| | - Jacqueline Attia
- Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
| | - J. Lloyd Michener
- Department of Family Medicine & Community Health, Duke School of Medicine, Durham, NC, USA
| | - Linda B. Cottler
- Department of Epidemiology, Colleges of Public Health and Health Professions and Medicine, University of Florida, Gainesville, FL, USA
| | - Sergio A. Aguilar-Gaxiola
- Center for Reducing Health Disparities, University of California – Davis School of Medicine, Sacramento, CA, USA
- Clinical and Translational Science Center, Department of Internal Medicine, School of Medicine, Sacramento, CA, USA
| |
Collapse
|
3
|
Havas F, Krispin S, Cohen M, Loing E, Attia J. 238 Alleviation of neurogenic inflammation and reduction of skin aging signs, by blocking psychological stress signaling with a natural Cistus creticus extract. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.09.249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
4
|
Plotnikoff R, Jansson A, Duncan M, Smith J, Bauman A, Attia J, Lubans D. A multi-component, community-based outdoor gym intervention: the ecofit effectiveness trial. J Sci Med Sport 2022. [DOI: 10.1016/j.jsams.2022.09.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
5
|
Bredella MA, Rubio DM, Attia J, Kelly TH, McIntosh S, Meagher EA, Pusek S, Rubio M, Tsevat J, Umans JG. The Virtual CTSA Visiting Scholar Program to Support Early-Stage Clinical and Translational Researchers: Implementation and Outcomes. Acad Med 2022; 97:1311-1316. [PMID: 35263302 PMCID: PMC10732303 DOI: 10.1097/acm.0000000000004645] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
In addition to restrictions on conducting research, COVID-19-related travel bans and scientific meeting cancellations have negatively affected scholars in the Clinical and Translational Science Award (CTSA) Mentored Career Development Award (KL2) program. In response, a national virtual visiting scholar program was developed to provide opportunity for KL2 scholars to be virtual visiting professors at another CTSA hub, meet faculty and scholars, and expand networks and build collaborations. This article describes the design and short-term outcomes of the virtual CTSA Visiting Scholar Program. In 2020, a working group designed core program elements and developed an application and selection process. Anonymized surveys were sent to scholars post visit and to scholars and program directors 6 months post visit to evaluate their experience and solicit suggestions for improvements. Between November 2020 and May 2021, 56 KL2 scholars and 27 hubs participated. Forty-five (80.4%) participating scholars responded to the initial survey. Nearly all scholars (44, 97.7%) agreed their experience was valuable. All respondents indicated they would recommend the program to other KL2 scholars. For the 6-month survey, the response rate was 87.5% (49/56). Within 6 months of their visit, 36 (73.5%) respondents had contacted at least one person at the host hub and for 17 (34.7%) respondents, new collaborations with the host hub ensued. Twenty-five of 27 (92.6%) host hubs responded to the survey. Most (21, 84.0%) agreed that hearing visiting scholar talks was valuable to their own scholars and 23 (92%) indicated likelihood of their hub participating in future round of the program. The virtual Visiting Scholar Program provided KL2 scholars an opportunity to virtually visit another CTSA hub, present their research, and meet with faculty and other scholars to expand their networks. Although geared to KL2 scholars, this model is potentially generalizable to other nationally coordinated career development programs.
Collapse
Affiliation(s)
- Miriam A Bredella
- M.A. Bredella is professor of radiology, vice chair, Department of Radiology, Massachusetts General Hospital, and director, KL2/Catalyst Medical Research Investigator Training Program, Harvard Catalyst, The Harvard Clinical and Translational Science Center, Harvard Medical School, Boston, Massachusetts
| | - Doris M Rubio
- D.M. Rubio is professor of medicine, biostatistics, bioinformatics, and clinical and translational science, assistant vice chancellor for clinical research education and training, Health Sciences, director, Institute for Clinical Research Education, and director, KL2, Team Science, and Workforce Development, Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
| | - Jacqueline Attia
- J. Attia is health project coordinator, Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York
| | - Thomas H Kelly
- T.H. Kelly is Robert Straus Professor and chair, Department of Behavioral Science, College of Medicine, associate dean for research and PhD faculty affairs, College of Nursing, and director, KL2 and Workforce Development, Center for Clinical and Translational Science, University of Kentucky, Lexington, Kentucky
| | - Scott McIntosh
- S. McIntosh is associate professor and survey team faculty lead, Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, New York
| | - Emma A Meagher
- E.A. Meagher is professor of medicine and pharmacology, director, Translational Research Education, Institute for Translational Medicine and Therapeutics, and vice dean, Clinical Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Susan Pusek
- S. Pusek is director, Education Programs, North Carolina TraCS Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
| | - Mercedes Rubio
- M. Rubio is program director, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland
| | - Joel Tsevat
- J. Tsevat is professor of medicine, Joaquin G. Cigarroa, Jr., MD, Distinguished Chair, director, ReACH Center, director, KL2 Program, University of Texas Health Science Center at San Antonio, and professor of population health, Dell Medical School, University of Texas at Austin, and Institute for the Integration of Medicine and Science, Center for Research to Advance Community Health, Department of Medicine, Joe R. and Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas
| | - Jason G Umans
- J.G. Umans is KL2 program director, Georgetown-Howard Universities Center for Clinical and Translational Science, associate professor of medicine and of obstetrics and gynecology, Georgetown University, Washington, DC, scientific director, Biomarker, Biochemistry and Biorepository Core, and scientific director, Field Studies Division, MedStar Health Research Institute, Hyattsville, Maryland
| |
Collapse
|
6
|
Duroux R, Baillif V, Havas F, Farge M, Maurin A, Suere T, VanGoethem E, Attia J. Targeting inflammation and pro-resolving mediators with Anetholea anisita extract to improve scalp condition. Int J Cosmet Sci 2022; 44:614-624. [PMID: 35979727 DOI: 10.1111/ics.12813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2022] [Revised: 08/01/2022] [Accepted: 08/16/2022] [Indexed: 11/28/2022]
Abstract
OBJECTIVE A critical and often-overlooked factor that may give rise to dandruff and oily hair is the intrinsic quality of the scalp stratum corneum (SC), which is often unbalanced and susceptible to external aggressions. Addressing the inflammation element of unhealthy scalp plays an important role in promoting healthy-looking and feeling hair. Although specialized pro-resolving lipid mediators (SPMs) have been studied in the skin to end the inflammation process and promote tissue regeneration, no studies have been provided in the scalp. This study aims to investigate SPMs expression and its role in improving scalp integrity and consequently improving hair appearance using an Anetholea anisita extract. METHODS The effect of Anetholea anisita extract was investigated in vitro on human follicle dermal papilla cells (HFDPC), evaluating its antioxidant and anti-inflammatory properties by fluorescence staining and ELISA, respectively. Ex-vivo measurement of the volume of human scalp sebaceous glands was performed using X-ray microtomography (micro CT). The extract was then clinically tested on a population of dandruff sufferers presenting oily hair. Volunteers' sebum was collected on the scalp and analyzed by LC-MS/MS or ELISA to identify SPMs and pro-inflammatory markers. Scalp integrity was assessed by measuring the pH and the TEWL. Sebum production, dandruff and hair gloss were also evaluated. RESULTS Anetholea anisita extract reduced IL-8 and Reactive Oxygen Species (ROS) generation in HFDPC. Interestingly, this extract also decreased the volume of sebaceous glands as revealed by micro CT. This result was confirmed in vivo by a decrease of sebum production in volunteers. Moreover, SPMs were analyzed and detected in the scalp for the first time. An increase of Lipoxin B4 (LxB4) and Resolvin D1 and D2 (RvD1 and RvD2) was observed after Anetholea anisita treatment as well as decreased of pro-inflammatory sebum mediators expression such as PGE2, LTB4 and IL-8. Consequently, the scalp barrier was reinforced as observed through improved transepidermal water loss (TEWL) and skin surface pH, reducing dandruff and improving hair health. CONCLUSION The present results suggest the potential of cosmetic applications of Anetholea anisita extract to improve scalp health by targeting inflammation pathways to decrease dandruff and improve hair condition.
Collapse
Affiliation(s)
- R Duroux
- International Flavors & Fragrances-Lucas Meyer Cosmetics, Toulouse, France
| | | | - F Havas
- International Flavors & Fragrances-Lucas Meyer Cosmetics, Faran 4, Yavne, Israel
| | - M Farge
- International Flavors & Fragrances-Lucas Meyer Cosmetics, Toulouse, France
| | - A Maurin
- International Flavors & Fragrances-Lucas Meyer Cosmetics, Toulouse, France
| | - T Suere
- International Flavors & Fragrances-Lucas Meyer Cosmetics, Toulouse, France
| | | | - J Attia
- International Flavors & Fragrances-Lucas Meyer Cosmetics, Toulouse, France
| |
Collapse
|
7
|
Smyth SS, Coller BS, Jackson RD, Kern PA, McIntosh S, Meagher EA, Rubio DM, Sandberg K, Tsevat J, Umans JG, Attia J, Baker HL, Nagel JD, McMullen CA, Rosemond E. KL2 scholars' perceptions of factors contributing to sustained translational science career success. J Clin Transl Sci 2021; 6:e34. [PMID: 35433037 PMCID: PMC9003634 DOI: 10.1017/cts.2021.886] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2021] [Revised: 12/21/2021] [Accepted: 12/22/2021] [Indexed: 11/05/2022] Open
Abstract
Introduction Identifying the most effective ways to support career development of early stage investigators in clinical and translational science should yield benefits for the biomedical research community. Institutions with Clinical and Translational Science Awards (CTSA) offer KL2 programs to facilitate career development; however, the sustained impact has not been widely assessed. Methods A survey comprised of quantitative and qualitative questions was sent to 2144 individuals that had previously received support through CTSA KL2 mechanisms. The 547 responses were analyzed with identifying information redacted. Results Respondents held MD (47%), PhD (36%), and MD/PhD (13%) degrees. After KL2 support was completed, physicians' time was divided 50% to research and 30% to patient care, whereas PhD respondents devoted 70% time to research. Funded research effort averaged 60% for the cohort. Respondents were satisfied with their career progression. More than 95% thought their current job was meaningful. Two-thirds felt confident or very confident in their ability to sustain a career in clinical and translational research. Factors cited as contributing to career success included protected time, mentoring, and collaborations. Conclusion This first large systematic survey of KL2 alumni provides valuable insight into the group's perceptions of the program and outcome information. Former scholars are largely satisfied with their career choice and direction, national recognition of their expertise, and impact of their work. Importantly, they identified training activities that contributed to success. Our results and future analysis of the survey data should inform the framework for developing platforms to launch sustaining careers of translational scientists.
Collapse
Affiliation(s)
- Susan S. Smyth
- University of Arkansas for Medical Sciences, Little Rock, AR, USA
| | | | | | | | | | | | | | | | - Joel Tsevat
- University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
| | | | | | - Heather L. Baker
- National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA
| | - Joan D. Nagel
- National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA
| | | | - Erica Rosemond
- National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
8
|
Sancheznieto F, Sorkness CA, Attia J, Buettner K, Edelman D, Hobbs S, McIntosh S, McManus LM, Sandberg K, Schnaper HW, Scholl L, Umans JG, Weavers K, Windebank A, McCormack WT. Clinical and translational science award T32/TL1 training programs: program goals and mentorship practices. J Clin Transl Sci 2021; 6:e13. [PMID: 35211339 PMCID: PMC8826009 DOI: 10.1017/cts.2021.884] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2021] [Revised: 12/15/2021] [Accepted: 12/16/2021] [Indexed: 01/29/2023] Open
Abstract
INTRODUCTION A national survey characterized training and career development for translational researchers through Clinical and Translational Science Award (CTSA) T32/TL1 programs. This report summarizes program goals, trainee characteristics, and mentorship practices. METHODS A web link to a voluntary survey was emailed to 51 active TL1 program directors and administrators. Descriptive analyses were performed on aggregate data. Qualitative data analysis used open coding of text followed by an axial coding strategy based on the grounded theory approach. RESULTS Fifty out of 51 (98%) invited CTSA hubs responded. Training program goals were aligned with the CTSA mission. The trainee population consisted of predoctoral students (50%), postdoctoral fellows (30%), and health professional students in short-term (11%) or year-out (9%) research training. Forty percent of TL1 programs support both predoctoral and postdoctoral trainees. Trainees are diverse by academic affiliation, mostly from medicine, engineering, public health, non-health sciences, pharmacy, and nursing. Mentor training is offered by most programs, but mandatory at less than one-third of them. Most mentoring teams consist of two or more mentors. CONCLUSIONS CTSA TL1 programs are distinct from other NIH-funded training programs in their focus on clinical and translational research, cross-disciplinary approaches, emphasis on team science, and integration of multiple trainee types. Trainees in nearly all TL1 programs were engaged in all phases of translational research (preclinical, clinical, implementation, public health), suggesting that the CTSA TL1 program is meeting the mandate of NCATS to provide training to develop the clinical and translational research workforce.
Collapse
Affiliation(s)
- Fátima Sancheznieto
- University of Wisconsin Institute for Clinical and Translational Research, Madison, WI, USA
| | - Christine A. Sorkness
- University of Wisconsin Institute for Clinical and Translational Research, Madison, WI, USA
| | - Jacqueline Attia
- Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
| | - Kathryn Buettner
- Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
| | - David Edelman
- Division of General Internal Medicine, Duke University School of Medicine, Durham, NC, USA
| | - Stuart Hobbs
- The Ohio State University, Center for Clinical and Translational Science, Columbus, OH, USA
| | - Scott McIntosh
- Center for Leading Innovation and Collaboration, Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA
| | | | - Kathryn Sandberg
- Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA
| | - H. William Schnaper
- Northwestern University Clinical and Translational Sciences Institute, Northwestern University, Chicago, IL, USA
| | | | - Jason G. Umans
- Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA
| | | | | | - Wayne T. McCormack
- Clinical & Translational Science Institute, Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA
| |
Collapse
|
9
|
Siribumrungwong B, Wilasrusmee C, Orrapin S, Srikuea K, Benyakorn T, McKay G, Attia J, Rerkasem K, Thakkinstian A. Interventions for great saphenous vein reflux: network meta-analysis of randomized clinical trials. Br J Surg 2021; 108:244-255. [PMID: 33793723 PMCID: PMC10364879 DOI: 10.1093/bjs/znaa101] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2020] [Revised: 10/12/2020] [Accepted: 11/01/2020] [Indexed: 11/14/2022]
Abstract
BACKGROUND A variety of endovascular and open surgical interventions exist to treat great saphenous vein reflux. However, comparisons of treatment outcomes have been inconsistent. METHODS A systematic review and network meta-analysis of RCTs was performed to compare rates of incomplete stripping or non-occlusion of the great saphenous vein with or without reflux (anatomical failure) at early, mid- and long-term follow-up; and secondary outcomes (reintervention and clinical recurrence) among intervention groups. The surface under the cumulative ranking curve (SUCRA) method was used to estimate the probability of the intervention with the lowest anatomical failure rates. RESULTS Some 72 RCTs were included. Comparisons of endothermal techniques with open surgery were mostly not significantly different, except for endovenous laser ablation (EVLA), which had higher long-term anatomical failure rates (pooled risk ratio (RR) 1.87, 95 per cent c.i. 1.14 to 3.07). Mechanochemical ablation had higher anatomical failure rates than radiofrequency ablation (RFA) (pooled RR 2.77, 1.38 to 5.53), and cyanoacrylate closure (CAC) had a RR 0.56 (0.34 to 0.93) times lower than either RFA or EVLA at the early term. Ultrasound-guided foam sclerotherapy had a higher risk of anatomical failure and reintervention than open surgery, with the lowest SUCRA value, and CAC was ranked first, third and first for best intervention for anatomical failure at early, mid and long term respectively. However, clinical recurrence rates were not significantly different between all comparisons. CONCLUSION Mechanochemical ablation and ultrasound-guided foam sclerotherapy performed poorly, with higher anatomical failure rates in the long term. The other treatment modalities had similar rates of anatomical failure in the short and mid term.
Collapse
Affiliation(s)
- B Siribumrungwong
- Division of Vascular and Endovascular Surgery, Department of Surgery, Thammasat University Hospital, Pathum Thani, Thailand.,Centre of Excellence in Applied Epidemiology, Thammasat University Hospital, Thammasat University, Pathum Thani, Thailand
| | - C Wilasrusmee
- Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - S Orrapin
- Division of Vascular and Endovascular Surgery, Department of Surgery, Thammasat University Hospital, Pathum Thani, Thailand
| | - K Srikuea
- Division of Vascular and Endovascular Surgery, Department of Surgery, Thammasat University Hospital, Pathum Thani, Thailand
| | - T Benyakorn
- Division of Vascular and Endovascular Surgery, Department of Surgery, Thammasat University Hospital, Pathum Thani, Thailand
| | - G McKay
- Centre for Public Health, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, UK
| | - J Attia
- Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, and Hunter Medical Research Institute, NSW, Australia
| | - K Rerkasem
- Division of Vascular and Endovascular Surgery, Department of Surgery, Faculty of Medicine; Non-Communicable Disease Centre of Excellence, Research Institute of Health Sciences, Chiang Mai University, Chiang Mai, Thailand
| | - A Thakkinstian
- Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| |
Collapse
|
10
|
Havas F, Krispin S, Cohen M, Borenstein-Auerbach N, Loing E, Farge M, Suere T, Attia J. 497 A Dunaliella salina extract counteracts skin aging under intense solar irradiation thanks to its anti-glycation and anti-inflammatory properties. J Invest Dermatol 2021. [DOI: 10.1016/j.jid.2021.02.522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Wattanayingcharoenchai R, Rattanasiri S, Charakorn C, Attia J, Thakkinstian A. Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis. BJOG 2021; 128:25-35. [PMID: 32558987 PMCID: PMC7754428 DOI: 10.1111/1471-0528.16366] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/05/2020] [Indexed: 01/17/2023]
Abstract
BACKGROUND The efficacy of hormonal regimens for the prevention of endometrioma recurrence in women who have undergone conservative surgery is still controversial. OBJECTIVE To compare the efficacy of different hormonal regimens in this context and to rank them. SEARCH STRATEGY MEDLINE and Scopus databases were searched through January 2020. SELECTION CRITERIA Randomised controlled trials (RCTs) or cohorts, comparing the effect of any pair of interventions (i.e. cyclic oral contraceptives [OC], continuous OC, gonadotropin-releasing hormone agonist [GnRHa], dienogest [DNG], levonorgestrel-releasing intrauterine system [LNG-IUS] and expectant management) on endometrioma recurrence were selected. DATA COLLECTION AND ANALYSIS Data were independently extracted by two reviewers. Relative treatment effects were estimated using network meta-analysis (NMA) and ranked in descending order. MAIN RESULTS Six RCTs (675 patients) and 16 cohorts (3089 patients) were included. NMA of the RCTs involving expectant management, cyclic OC, continuous OC, GnRHa and GnRHa + LNG-IUS, showed that all hormonal regimens had a nonsignificant lower risk of endometrioma recurrence compared with expectant management. NMA of the cohorts involving expectant, cyclic OC, continuous OC, GnRHa, DNG, LNG-IUS, GnRHa + OC, and GnRHa + LNG-IUS indicated that LNG-IUS, DNG, continuous OC, GnRHa + OC and cyclic OC had a significantly lower risk of endometrioma recurrence than expectant management. LNG-IUS was ranked highest, followed by DNG and GnRHa + LNG-IUS. Long-term use of hormonal treatment either OC or progestin had a significantly lower risk of endometrioma recurrence than expectant treatment. CONCLUSION In the NMA of RCTs, there was no evidence supporting hormonal treatment for postoperative prevention of endometrioma recurrence. This was at odds with the cohort evidence, which found the protective effect of OC and progestin regimens, especially long-term treatment. Large-scale RCTs of these agents are still required. TWEETABLE ABSTRACT Hormonal regimens given as long-term treatment tend to reduce risk of endometrioma recurrence after conservative surgery.
Collapse
Affiliation(s)
- R Wattanayingcharoenchai
- Department of Clinical Epidemiology and BiostatisticsFaculty of Medicine Ramathibodi HospitalMahidol UniversityBangkokThailand,Department of Obstetrics and GynaecologyFaculty of Medicine Ramathibodi HospitalMahidol UniversityBangkokThailand
| | - S Rattanasiri
- Department of Clinical Epidemiology and BiostatisticsFaculty of Medicine Ramathibodi HospitalMahidol UniversityBangkokThailand
| | - C Charakorn
- Department of Clinical Epidemiology and BiostatisticsFaculty of Medicine Ramathibodi HospitalMahidol UniversityBangkokThailand,Department of Obstetrics and GynaecologyFaculty of Medicine Ramathibodi HospitalMahidol UniversityBangkokThailand
| | - J Attia
- Centre for Clinical Epidemiology and BiostatisticsSchool of Medicine and Public HealthFaculty of Health and MedicineUniversity of NewcastleNew LambtonAustralia
| | - A Thakkinstian
- Department of Clinical Epidemiology and BiostatisticsFaculty of Medicine Ramathibodi HospitalMahidol UniversityBangkokThailand
| |
Collapse
|
12
|
Attia J, Borel M, Barreau M, Le Toquin E, Lesouhaitier O, Loing E. 353 A polylysine dendrigraft able to balance acneic and non acneic strains of Cutibacterium acnes to prevent acne and skin imperfections. J Invest Dermatol 2020. [DOI: 10.1016/j.jid.2020.03.360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
13
|
Oftedal S, Holliday E, Attia J, Brown W, Collins C, Ewald B, Glozier N, McEvoy M, Morgan P, Plotnikoff R, Stamatakis E, Vandelanotte C, Duncan M. Daily steps and diet quality, but not sleep, are related to mortality in older Australians. J Sci Med Sport 2019. [DOI: 10.1016/j.jsams.2019.08.244] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
14
|
Havas F, Krispin S, Borenstein N, Perolat A, Attia J, Loing E. 241 Skin radiance improvements with Hylocereus Undatus fruit extract influencing skin microbiome. J Invest Dermatol 2019. [DOI: 10.1016/j.jid.2019.07.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
15
|
Almeida Scalvino S, Chapelle A, Hajem N, Lati E, Gasser P, Choulot JC, Michel L, Hocquaux M, Loing E, Attia J, Wdzieczak-Bakala J. Efficacy of an agonist of α-MSH, the palmitoyl tetrapeptide-20, in hair pigmentation. Int J Cosmet Sci 2018; 40:516-524. [PMID: 30222197 DOI: 10.1111/ics.12494] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Accepted: 09/04/2018] [Indexed: 12/11/2022]
Abstract
OBJECTIVE Hair greying (i.e., canities) is a component of chronological ageing and occurs regardless of gender or ethnicity. Canities is directly linked to the loss of melanin and increase in oxidative stress in the hair follicle and shaft. To promote hair pigmentation and reduce the hair greying process, an agonist of α-melanocyte-stimulating hormone (α-MSH), a biomimetic peptide (palmitoyl tetrapeptide-20; PTP20) was developed. The aim of this study was to describe the effects of the designed peptide on hair greying. METHODS Effect of the PTP20 on the enzymatic activity of catalase and the production of H2 O2 by Human Follicle Dermal Papilla Cells (HFDPC) was evaluated. Influence of PTP20 on the expression of melanocortin receptor-1 (MC1-R) and the production of melanin were investigated. Enzymatic activity of sirtuin 1 (SIRT1) after treatment with PTP20 was also determined. Ex vivo studies using human micro-dissected hairs allowed to visualize the effect of PTP20 on the expression in hair follicle of catalase, TRP-1, TRP-2, Melan-A, ASIP, and MC1-R. These investigations were completed by a clinical study on 15 human male volunteers suffering from premature canities. RESULTS The in vitro and ex vivo studies revealed the capacity of the examined PTP20 peptide to enhance the expression of catalase and to decrease (30%) the intracellular level of H2 O2 . Moreover, PTP20 was shown to activate in vitro and ex vivo the melanogenesis process. In fact, an increase in the production of melanin was shown to be correlated with elevated expression of MC1-R, TRP-1, and Melan-A, and with the reduction in ASIP expression. A modulation on TRP-2 was also observed. The pivotal role of MC1-R was confirmed on protein expression analysed on volunteer's plucked hairs after 3 months of the daily application of lotion containing 10 ppm of PTP20 peptide. CONCLUSION The current findings demonstrate the ability of the biomimetic PTP20 peptide to preserve the function of follicular melanocytes. The present results suggest potential cosmetic application of this newly designed agonist of α-MSH to promote hair pigmentation and thus, reduce the hair greying process.
Collapse
Affiliation(s)
| | - A Chapelle
- ICSN, UPR2301 CNRS, 91198, Gif-sur-Yvette, France
| | - N Hajem
- Ales Groupe, 95871, Bezons, France
| | - E Lati
- Laboratoire BIO-EC, 91160, Longjumeau, France
| | - P Gasser
- Laboratoire BIO-EC, 91160, Longjumeau, France
| | | | - L Michel
- Inserm UMR976, 75475, Paris, France
| | - M Hocquaux
- IFF-Lucas Meyer Cosmetics, 31036, Toulouse, France
| | - E Loing
- IFF-Lucas Meyer Cosmetics, G1V4W2, Québec, Canada
| | - J Attia
- IFF-Lucas Meyer Cosmetics, 31036, Toulouse, France
| | | |
Collapse
|
16
|
Attia J, Borel M, Hocquaux M, Loing E. 1384 Innovative palmitoyl tetrapeptide-20: A promising solution to fight grey hair. J Invest Dermatol 2018. [DOI: 10.1016/j.jid.2018.03.1401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
17
|
Garland J, Tse R, Anne S, Oldmeadow C, Attia J, Vilain R, Elstub H, Kesha K, Stables S, Kuo T, Sunderland M, Garland S, Lam L, Cala A. Use of post mortem vitreous humour electrolytes in diagnosing salt water drowning deaths. Pathology 2018. [DOI: 10.1016/j.pathol.2017.12.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
18
|
Paganin F, Mangiapan G, Proust A, Prudhomme A, Attia J, Marchand-Adam S, Pellet F, Milhe F, Melloni B, Bernady A, Raspaud C, Nocent C, Berger P, Guilleminault L. Lung function parameters in omalizumab responder patients: An interesting tool? Allergy 2017; 72:1953-1961. [PMID: 28517027 DOI: 10.1111/all.13202] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/04/2017] [Indexed: 12/26/2022]
Abstract
BACKGROUND Omalizumab, an anti-IgE antibody, is used to treat patients with severe allergic asthma. The evolution of lung function parameters over time and the difference between omalizumab responder and nonresponder patients remain inconclusive. The objective of this real-life study was to compare the changes in forced expiratory volume in 1 second (FEV1) of omalizumab responders and nonresponders at 6 months. METHODS A multicenter analysis was performed in 10 secondary and tertiary institutions. Lung function parameters (forced vital capacity (FVC), pre- and postbronchodilator FEV1, residual volume (RV), and total lung capacity (TLC) were determined at baseline and at 6 months. Omalizumab response was assessed at the 6-month visit. In the omalizumab responder patients, lung function parameters were also obtained at 12, 18, and 24 months. RESULTS Mean prebronchodilator FEV1 showed improvement in responders at 6 months, while a decrease was observed in nonresponders (+0.2±0.4 L and -0.1±0.4 L, respectively, P<.01). After an improvement at 6 months, pre- and postbronchodilator FEV1 remained stable at 12, 18, and 24 months. The FEV1/FVC remained unchanged over time, but the proportion of patients with an FEV1/FVC ratio <0.7 decreased at 6, 12, 18, and 24 months (55.2%, 54.0%, 54.0%, and 44.8%, respectively, P<.05). Mean RV values decreased at 6 months but increased at 12 months and 24 months (P<.05). Residual volume/total lung capacity (RV/TLC) ratio decreased at 6 months and remained unchanged at 24 months. CONCLUSION After omalizumab initiation, FEV1 improved at 6 months in responder patients and then remained stable for 2 years. RV and RV/TLC improved at 6 months.
Collapse
Affiliation(s)
- F. Paganin
- INSERM U 600, UMR 6212; Université de la Méditerranée.; Marseille France
- Université de la Réunion; St Denis France
| | - G. Mangiapan
- Service de Pneumologie; CHIC de Créteil; Créteil France
| | - A. Proust
- Service de Pneumologie; CHU de Nimes; Tarbes France
| | - A. Prudhomme
- Service de Pneumologie; CHG de Bigorre; Tarbes France
| | - J. Attia
- Cabinet de Pneumologie; Bastia France
| | | | - F. Pellet
- Cabinet de Pneumologie; Bordeaux France
| | - F. Milhe
- Service de Pneumologie; Polyclinique des Fleurs; Ollioules France
| | - B. Melloni
- Service de Pneumologie; CHU de Limoges; Limoges France
| | - A. Bernady
- Service de Pneumologie; Centre médical Toki Eder; Cambo les Bains France
| | - C. Raspaud
- Service de Pneumologie; Clinique Pasteur; Toulouse France
| | - C. Nocent
- Service de Pneumologie et d'allergologie; CH de la côte Basque; Bayonne France
| | - P. Berger
- Centre de Recherche Cardio-thoracique de Bordeaux; Univ. Bordeaux, U1045, CIC1401; Bordeaux France
- Centre de Recherche Cardio-thoracique de Bordeaux; INSERM, U1045, CIC1401; Bordeaux France
- Service d'Exploration Fonctionnelle Respiratoire; CHU de Bordeaux, CIC1401; Pessac France
| | - L. Guilleminault
- Université de la Réunion; St Denis France
- Service de Pneumologie; CHU Reunion/GHSR; Saint-Pierre France
- INSERM; UMR 1188 Diabète Athérothrombose Thérapies Réunion Océan Indien (DéTROI); Sainte-Clotilde France
| |
Collapse
|
19
|
Attia J, Shortt M, Bégin-Lavallée V, Tubia C, Loing E. 284 Backhousia citriodora leaf extract: A new active solution to control hyper-seborrhea for multi-ethnic skins. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
20
|
Attia J, Borel M, Bakala J, Almeida S, Michel L, Lati E, Choulot J, Hocquaux M, Loing E. 249 Innovative hair care biomimetic peptide: A promising solution to promote hair pigmentation and counteract the graying hair process. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.07.247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
21
|
Rowe CW, Haider AS, Viswanathan D, Jones M, Attia J, Wynne K, Acharya S. Insulin resistance correlates with maculopathy and severity of retinopathy in young adults with Type 1 Diabetes Mellitus. Diabetes Res Clin Pract 2017; 131:154-160. [PMID: 28750218 DOI: 10.1016/j.diabres.2017.06.022] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/02/2017] [Revised: 05/19/2017] [Accepted: 06/15/2017] [Indexed: 01/17/2023]
Abstract
AIMS To assess the relationship between insulin resistance (IR), retinopathy and maculopathy in young adults with Type 1 diabetes mellitus. METHODS A cross-sectional study at a regional Australian tertiary hospital. Retinal pathology, assessed by colour fundus photography, was correlated with two surrogate measures of IR: estimated Glucose Disposal Rate (eGDR) and Insulin Sensitivity Score (ISS), where lower scores reflect greater IR. RESULTS 107 patients were recruited, with mean age 24.7years, 53% male, and mean duration of disease 10.8years. Mean eGDR scores (5.6vs 8.0 p<0.001) and ISS (4.7vs 7.9, p<0.001) were lower in subjects having at least moderate non-proliferative diabetic retinopathy (NPDR; relative to nil/mild-NPDR). Similarly, mean eGDR (4.2vs 6.2, p=0.001) and ISS (3.8vs 6.1, p=0.003) were lower in patients with maculopathy. Multivariate logistic regression modelling was used to control for confounding. For retinopathy severity, a unit increase in eGDR or ISS (representing lower IR) was associated with a 50% decrease in odds of moderate-NPDR or worse (eGDR OR 0.5, 95%CI 0.32-0.77, p=0.002; ISS OR 0.49, 95%CI 0.29-0.84, p=0.01). A unit increase in eGDR or ISS was associated with a 46-56% decrease in odds of maculopathy (eGDR OR 0.54, 95%CI 0.37-0.81, p=0.003; ISS OR 0.44, 95%CI 0.22-0.88, p=0.02). CONCLUSIONS IR correlates with more severe retinopathy in young adults with Type 1DM. This is the first description of a correlation between IR and maculopathy in Type 1DM, warranting further evaluation. Prospective studies examining whether reducing IR can improve microvascular complications are required.
Collapse
Affiliation(s)
- C W Rowe
- Department of Endocrinology and Diabetes, John Hunter Hospital, Newcastle, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, Australia.
| | - A S Haider
- School of Medicine and Public Health, University of Newcastle, Callaghan, Australia; Department of Ophthalmology, John Hunter Hospital, Newcastle, Australia
| | - D Viswanathan
- Department of Ophthalmology, John Hunter Hospital, Newcastle, Australia
| | - M Jones
- Clinical Research Design, IT, and Statistical Support (CReDITSS) Unit, Hunter Medical Research Institute, Newcastle, Australia
| | - J Attia
- School of Medicine and Public Health, University of Newcastle, Callaghan, Australia; Clinical Research Design, IT, and Statistical Support (CReDITSS) Unit, Hunter Medical Research Institute, Newcastle, Australia
| | - K Wynne
- Department of Endocrinology and Diabetes, John Hunter Hospital, Newcastle, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, Australia
| | - S Acharya
- Department of Endocrinology and Diabetes, John Hunter Hospital, Newcastle, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, Australia
| |
Collapse
|
22
|
Paterson MA, Smart CEM, Lopez PE, Howley P, McElduff P, Attia J, Morbey C, King BR. Increasing the protein quantity in a meal results in dose-dependent effects on postprandial glucose levels in individuals with Type 1 diabetes mellitus. Diabet Med 2017; 34:851-854. [PMID: 28257160 DOI: 10.1111/dme.13347] [Citation(s) in RCA: 44] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/27/2017] [Indexed: 12/25/2022]
Abstract
AIM To determine the glycaemic impact of increasing protein quantities when consumed with consistent amounts of carbohydrate in individuals with Type 1 diabetes on intensive insulin therapy. METHODS Participants with Type 1 diabetes [aged 10-40 years, HbA1c ≤ 64 mmol/mol (8%), BMI ≤ 91st percentile] received a 30-g carbohydrate (negligible fat) test drink daily over 5 days in randomized order. Protein (whey isolate 0 g/kg carbohydrate, 0 g/kg lipid) was added in amounts of 0 (control), 12.5, 25, 50 and 75 g. A standardized dose of insulin was given for the carbohydrate. Postprandial glycaemia was assessed by 5 h of continuous glucose monitoring. RESULTS Data were collected from 27 participants (15 male). A dose-response relationship was found with increasing amount of protein. A significant negative relationship between protein dose and mean excursion was seen at the 30- and 60-min time points (P = 0.007 and P = 0.002, respectively). No significant relationship was seen at the 90- and 120-min time points. Thereafter, the dose-response relationship inverted, such that there was a significant positive relationship for each of the 150-300-min time points (P < 0.004). Mean glycaemic excursions were significantly greater for all protein-added test drinks from 150 to 300 min (P < 0.005) with the 75-g protein load, resulting in a mean excursion that was 5 mmol/l higher when compared with the control test drink (P < 0.001). CONCLUSIONS Increasing protein quantity in a low-fat meal containing consistent amounts of carbohydrate decreases glucose excursions in the early (0-60-min) postprandial period and then increases in the later postprandial period in a dose-dependent manner.
Collapse
Affiliation(s)
- M A Paterson
- Hunter Medical Research Institute, School of Medicine and Public Health, New Lambton Heights, Newcastle
- Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle
| | - C E M Smart
- Hunter Medical Research Institute, School of Medicine and Public Health, New Lambton Heights, Newcastle
- Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle
| | - P E Lopez
- Hunter Medical Research Institute, School of Medicine and Public Health, New Lambton Heights, Newcastle
- Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle
| | - P Howley
- School of Mathematics and Physical Sciences/Statistics, University of Newcastle, Callaghan
| | - P McElduff
- School of Mathematics and Physical Sciences/Statistics, University of Newcastle, Callaghan
| | - J Attia
- Hunter Medical Research Institute, School of Medicine and Public Health, New Lambton Heights, Newcastle
| | - C Morbey
- Aim Diabetes Management Centre, Newcastle, New South Wales, Australia
| | - B R King
- Hunter Medical Research Institute, School of Medicine and Public Health, New Lambton Heights, Newcastle
- Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle
| |
Collapse
|
23
|
Abdullah N, Abdul Murad NA, Mohd Haniff EA, Syafruddin SE, Attia J, Oldmeadow C, Kamaruddin MA, Abd Jalal N, Ismail N, Ishak M, Jamal R, Scott RJ, Holliday EG. Predicting type 2 diabetes using genetic and environmental risk factors in a multi-ethnic Malaysian cohort. Public Health 2017; 149:31-38. [PMID: 28528225 DOI: 10.1016/j.puhe.2017.04.003] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2016] [Revised: 03/17/2017] [Accepted: 04/05/2017] [Indexed: 12/22/2022]
Abstract
OBJECTIVE Malaysia has a high and rising prevalence of type 2 diabetes (T2D). While environmental (non-genetic) risk factors for the disease are well established, the role of genetic variations and gene-environment interactions remain understudied in this population. This study aimed to estimate the relative contributions of environmental and genetic risk factors to T2D in Malaysia and also to assess evidence for gene-environment interactions that may explain additional risk variation. STUDY DESIGN This was a case-control study including 1604 Malays, 1654 Chinese and 1728 Indians from the Malaysian Cohort Project. METHODS The proportion of T2D risk variance explained by known genetic and environmental factors was assessed by fitting multivariable logistic regression models and evaluating McFadden's pseudo R2 and the area under the receiver-operating characteristic curve (AUC). Models with and without the genetic risk score (GRS) were compared using the log likelihood ratio Chi-squared test and AUCs. Multiplicative interaction between genetic and environmental risk factors was assessed via logistic regression within and across ancestral groups. Interactions were assessed for the GRS and its 62 constituent variants. RESULTS The models including environmental risk factors only had pseudo R2 values of 16.5-28.3% and AUC of 0.75-0.83. Incorporating a genetic score aggregating 62 T2D-associated risk variants significantly increased the model fit (likelihood ratio P-value of 2.50 × 10-4-4.83 × 10-12) and increased the pseudo R2 by about 1-2% and AUC by 1-3%. None of the gene-environment interactions reached significance after multiple testing adjustment, either for the GRS or individual variants. For individual variants, 33 out of 310 tested associations showed nominal statistical significance with 0.001 < P < 0.05. CONCLUSION This study suggests that known genetic risk variants contribute a significant but small amount to overall T2D risk variation in Malaysian population groups. If gene-environment interactions involving common genetic variants exist, they are likely of small effect, requiring substantially larger samples for detection.
Collapse
Affiliation(s)
- N Abdullah
- School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia; UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - N A Abdul Murad
- UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - E A Mohd Haniff
- UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - S E Syafruddin
- UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - J Attia
- Clinical Research Design, IT and Statistical Support (CReDITSS) Unit, Hunter Medical Research Institute, Newcastle, NSW, Australia; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia
| | - C Oldmeadow
- Clinical Research Design, IT and Statistical Support (CReDITSS) Unit, Hunter Medical Research Institute, Newcastle, NSW, Australia; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia
| | - M A Kamaruddin
- UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - N Abd Jalal
- UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - N Ismail
- UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - M Ishak
- UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - R Jamal
- UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
| | - R J Scott
- School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia; Hunter Area Pathology Service, John Hunter Hospital, Newcastle, NSW, Australia
| | - E G Holliday
- Clinical Research Design, IT and Statistical Support (CReDITSS) Unit, Hunter Medical Research Institute, Newcastle, NSW, Australia; Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, NSW, Australia.
| |
Collapse
|
24
|
Joshi T, Oldmeadow C, Attia J, Wynne K. The duration of intrapartum maternal hyperglycaemia predicts neonatal hypoglycaemia in women with pre-existing diabetes. Diabet Med 2017; 34:725-731. [PMID: 28199038 DOI: 10.1111/dme.13337] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/25/2016] [Revised: 12/28/2016] [Accepted: 02/10/2017] [Indexed: 11/28/2022]
Abstract
AIM There is a high incidence of neonatal hypoglycaemia in neonates born to mothers with pre-existing diabetes. This often necessitates admission to the neonatal intensive care. Guidelines suggest maintaining intrapartum blood glucose levels (BGLs) of 4-7 mmol/l in women with diabetes to reduce the risk of neonatal hypoglycaemia. This study assessed whether intrapartum BGLs in women with pre-gestational Type 1 and 2 diabetes were predictive of neonatal hypoglycaemia. METHODS A retrospective analysis of 261 births delivered at a tertiary hospital in Australia from 2009 to 2014. RESULTS There were 122 cases of neonatal hypoglycaemia (glucose ≤ 2.6 mmol/l) in 261 births (47%). The mothers in the neonatal hypoglycaemia group spent less time with BGL in the range 4-7 mmol/l [55 ± 37% vs. 65 ± 35%, P = 0.02; odds ratio (OR) 0.992, P = 0.03] and more time with BGL in the 7-10 mmol/l range (31 ± 34% vs. 18 ± 27%, P = 0.003; OR 1.013, P = 0.003) compared with those without neonatal hypoglycaemia. Although statistically significant, receiver operating characteristic (ROC) curve analysis showed that time spent with maternal BGLs in the range 4-7 mmol/l [area under the curve (AUC) = 0.58] or 7-10 mmol (AUC = 0.60) was not strong enough to be a useful clinical predictor of neonatal hypoglycaemia. HbA1c in the second trimester of pregnancy (P = 0.02, OR 1.42) and percentage time spent in BGL range of 7-10 mmol/l (P = 0.001, OR 1.02) were both associated with a risk of neonatal hypoglycaemia in a logistic regression model. HbA1c in the third trimester (P = 0.07, OR 1.28) approached, but did not reach, significance. CONCLUSIONS These data support a BGL range of 4-7 mmol/l as an intrapartum target. Glycaemic control in the second trimester is associated with neonatal hypoglycaemia. Improvement in ante- and intrapartum glycaemic control may reduce neonatal hypoglycaemia in women with pre-existing diabetes.
Collapse
Affiliation(s)
- T Joshi
- Department of Diabetes, John Hunter Hospital, Newcastle, NSW, Australia
- Department of Medicine, John Hunter Hospital, Newcastle, NSW, Australia
- Faculty of Medicine and Health, University of Newcastle, Newcastle, NSW, Australia
| | - C Oldmeadow
- Faculty of Medicine and Health, University of Newcastle, Newcastle, NSW, Australia
- Hunter Medical Research Institute, Newcastle, NSW, Australia
| | - J Attia
- Department of Medicine, John Hunter Hospital, Newcastle, NSW, Australia
- Faculty of Medicine and Health, University of Newcastle, Newcastle, NSW, Australia
- Hunter Medical Research Institute, Newcastle, NSW, Australia
| | - K Wynne
- Department of Diabetes, John Hunter Hospital, Newcastle, NSW, Australia
- Department of Medicine, John Hunter Hospital, Newcastle, NSW, Australia
- Faculty of Medicine and Health, University of Newcastle, Newcastle, NSW, Australia
- Hunter Medical Research Institute, Newcastle, NSW, Australia
| |
Collapse
|
25
|
Attia J, Begin-Lavallee V, Tubia C, Loing E. 889 Lemon myrtle: A new anti-seborrheic extract for multi-ethnic skins. J Invest Dermatol 2017. [DOI: 10.1016/j.jid.2017.02.915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
26
|
Pons L, Till M, Alix E, Abel C, Boggio D, Bordes A, Caloone J, Raskin FC, Chatron N, Cordier MP, Fichez A, Labalme A, Lajeunesse C, Liaras É, Massoud M, Miribel J, Ollagnon E, Schluth-Bolard C, Vichier-Cerf A, Edery P, Attia J, Huissoud C, Rudigoz RC, Massardier J, Gaucherand P, Sanlaville D. Prenatal microarray comparative genomic hybridization: Experience from the two first years of activity at the Lyon university-hospital. J Gynecol Obstet Hum Reprod 2017; 46:275-283. [PMID: 28403926 DOI: 10.1016/j.jogoh.2016.11.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Revised: 11/07/2016] [Accepted: 11/17/2016] [Indexed: 11/17/2022]
Abstract
OBJECTIVES This study aims to describe how microarray comparative genomic hybridization (aCGH) has shifted to become a prenatal diagnosis tool at the Lyon university-hospital. MATERIALS AND METHODS This retrospective study included all patients who were referred in the 3 pluridisciplinary centers for prenatal diagnosis of the Lyon university-hospital and who received a prenatal aCGH between June 2013 and June 2015. aCGH was systematically performed in parallel with a karyotype, using the PréCytoNEM array design. RESULTS A total of 260 microarrays were performed for the following indications: 249 abnormal ultrasounds (95.8%), 7 characterizations of chromosomal rearrangements (2.7%), and 4 twins with no abnormal ultrasounds (1.5%). With a resolution of 1 mega base, we found 235 normal results (90.4%), 23 abnormal results (8.8%) and 2 non-returns (0.8%). For the chromosomal rearrangements visible on the karyotype, aCGH identified all of the 12 unbalanced rearrangements and did not identify the 2 balanced rearrangements. Among the fetuses with normal karyotypes, 11 showed abnormal microarray results, corresponding to unbalanced cryptic chromosomal rearrangements (4.2%). CONCLUSION Transferring aCGH to a prenatal diagnosis at the Lyon university-hospital has increased the detection rate of chromosomal abnormalities by 4.2% compared to the single karyotype.
Collapse
Affiliation(s)
- L Pons
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France; Université Claude-Bernard Lyon 1, 69008 Lyon, France.
| | - M Till
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France
| | - E Alix
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France
| | - C Abel
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France
| | - D Boggio
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France
| | - A Bordes
- Département d'obstétrique et de gynécologie, groupement hospitalier Est, HCL, 69500 Bron, France
| | - J Caloone
- Département d'obstétrique et de gynécologie, centre hospitalier de la Croix-Rousse, HCL, 69004 Lyon, France
| | - F C Raskin
- Département d'obstétrique et de gynécologie, centre hospitalier Lyon Sud, HCL, 69310 Pierre-Bénite, France
| | - N Chatron
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France; Université Claude-Bernard Lyon 1, 69008 Lyon, France; Équipe Gendev, CNRS UMR 5292, Inserm U1028, centre de recherche en neuroscience de Lyon, 69500 Bron, France
| | - M-P Cordier
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France
| | - A Fichez
- Département d'obstétrique et de gynécologie, centre hospitalier de la Croix-Rousse, HCL, 69004 Lyon, France
| | - A Labalme
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France
| | - C Lajeunesse
- Département d'obstétrique et de gynécologie, groupement hospitalier Est, HCL, 69500 Bron, France
| | - É Liaras
- Département d'obstétrique et de gynécologie, centre hospitalier Lyon Sud, HCL, 69310 Pierre-Bénite, France
| | - M Massoud
- Département d'obstétrique et de gynécologie, groupement hospitalier Est, HCL, 69500 Bron, France
| | - J Miribel
- Département d'obstétrique et de gynécologie, groupement hospitalier Est, HCL, 69500 Bron, France
| | - E Ollagnon
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France
| | - C Schluth-Bolard
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France; Université Claude-Bernard Lyon 1, 69008 Lyon, France; Équipe Gendev, CNRS UMR 5292, Inserm U1028, centre de recherche en neuroscience de Lyon, 69500 Bron, France
| | - A Vichier-Cerf
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France
| | - P Edery
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France; Université Claude-Bernard Lyon 1, 69008 Lyon, France; Équipe Gendev, CNRS UMR 5292, Inserm U1028, centre de recherche en neuroscience de Lyon, 69500 Bron, France
| | - J Attia
- Université Claude-Bernard Lyon 1, 69008 Lyon, France; Département d'obstétrique et de gynécologie, centre hospitalier Lyon Sud, HCL, 69310 Pierre-Bénite, France
| | - C Huissoud
- Département d'obstétrique et de gynécologie, centre hospitalier de la Croix-Rousse, HCL, 69004 Lyon, France
| | - R C Rudigoz
- Université Claude-Bernard Lyon 1, 69008 Lyon, France; Département d'obstétrique et de gynécologie, centre hospitalier de la Croix-Rousse, HCL, 69004 Lyon, France
| | - J Massardier
- Département d'obstétrique et de gynécologie, groupement hospitalier Est, HCL, 69500 Bron, France
| | - P Gaucherand
- Université Claude-Bernard Lyon 1, 69008 Lyon, France; Département d'obstétrique et de gynécologie, groupement hospitalier Est, HCL, 69500 Bron, France
| | - D Sanlaville
- Service de génétique, groupement hospitalier Est, HCL, 59, boulevard Pinel, 69677 Bron, France; Université Claude-Bernard Lyon 1, 69008 Lyon, France; Équipe Gendev, CNRS UMR 5292, Inserm U1028, centre de recherche en neuroscience de Lyon, 69500 Bron, France
| |
Collapse
|
27
|
Boonchan T, Wilasrusmee C, McEvoy M, Attia J, Thakkinstian A. Network meta-analysis of antibiotic prophylaxis for prevention of surgical-site infection after groin hernia surgery. Br J Surg 2017; 104:e106-e117. [PMID: 28121028 PMCID: PMC5299528 DOI: 10.1002/bjs.10441] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2016] [Revised: 10/03/2016] [Accepted: 11/01/2016] [Indexed: 12/11/2022]
Abstract
BACKGROUND First-generation cephalosporins (such as cefazolin) are recommended as antibiotic prophylaxis in groin hernia repair, but other broad-spectrum antibiotics have also been prescribed in clinical practice. This was a systematic review and network meta-analysis to compare the efficacy of different antibiotic classes for prevention of surgical-site infection (SSI) after hernia repair. METHODS RCTs were identified that compared efficacy of antibiotic prophylaxis on SSI after inguinal or femoral hernia repair from PubMed and Scopus databases up to March 2016. Data were extracted independently by two reviewers. Network meta-analysis was applied to assess treatment efficacy. The probability of being the best antibiotic prophylaxis was estimated using surface under the cumulative ranking curve (SUCRA) analysis. RESULTS Fifteen RCTs (5159 patients) met the inclusion criteria. Interventions were first-generation (7 RCTs, 1237 patients) and second-generation (2 RCTs, 532) cephalosporins, β-lactam/β-lactamase inhibitors (6 RCTs, 619) and fluoroquinolones (2 RCTs, 581), with placebo as the most common comparator (14 RCTs, 2190). A network meta-analysis showed that β-lactam/β-lactamase inhibitors and first-generation cephalosporins were significantly superior to placebo, with a pooled risk ratio of 0·44 (95 per cent c.i. 0·25 to 0·75) and 0·62 (0·42 to 0·92) respectively. However, none of the antibiotic classes was significantly different from the others. SUCRA results indicated that β-lactam/β-lactamase inhibitors and first-generation cephalosporins were ranked first and second respectively for best prophylaxis. CONCLUSION β-Lactam/β-lactamase inhibitors followed by first-generation cephalosporins ranked as the most effective SSI prophylaxis for adult patients undergoing groin hernia repair.
Collapse
Affiliation(s)
- T Boonchan
- Section for Clinical Epidemiology and Biostatistics and, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand
| | - C Wilasrusmee
- Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | - M McEvoy
- School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
| | - J Attia
- School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
| | - A Thakkinstian
- Section for Clinical Epidemiology and Biostatistics and, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| |
Collapse
|
28
|
Scott IA, Attia J. Cautionary tales in the interpretation of observational studies of effects of clinical interventions. Intern Med J 2017; 47:144-157. [DOI: 10.1111/imj.13167] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2016] [Revised: 06/13/2016] [Accepted: 06/14/2016] [Indexed: 11/27/2022]
Affiliation(s)
- I. A Scott
- Department of Internal Medicine and Clinical Epidemiology; Princess Alexandra Hospital; Brisbane Queensland Australia
- School of Clinical Medicine; University of Queensland; Brisbane Queensland Australia
| | - J. Attia
- Department of Medicine and Clinical Epidemiology, School of Medicine and Public Health; University of Newcastle; Newcastle New South Wales Australia
| |
Collapse
|
29
|
Faulkner S, Roselli S, Oldmeadow C, Attia J, Forbes JF, Walker MM, Hondermarck H. Abstract P6-03-03: Tropomyosin-related kinase A is overexpressed in HER2-positive breast cancers. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p6-03-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Collapse
Affiliation(s)
- S Faulkner
- School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute; School of Mathematical and Physical Sciences, The University of Newcastle, Callaghan, NSW, Australia; School of Public Health & Medicine, The University of Newcastle, Callaghan, NSW, Australia
| | - S Roselli
- School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute; School of Mathematical and Physical Sciences, The University of Newcastle, Callaghan, NSW, Australia; School of Public Health & Medicine, The University of Newcastle, Callaghan, NSW, Australia
| | - C Oldmeadow
- School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute; School of Mathematical and Physical Sciences, The University of Newcastle, Callaghan, NSW, Australia; School of Public Health & Medicine, The University of Newcastle, Callaghan, NSW, Australia
| | - J Attia
- School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute; School of Mathematical and Physical Sciences, The University of Newcastle, Callaghan, NSW, Australia; School of Public Health & Medicine, The University of Newcastle, Callaghan, NSW, Australia
| | - JF Forbes
- School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute; School of Mathematical and Physical Sciences, The University of Newcastle, Callaghan, NSW, Australia; School of Public Health & Medicine, The University of Newcastle, Callaghan, NSW, Australia
| | - MM Walker
- School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute; School of Mathematical and Physical Sciences, The University of Newcastle, Callaghan, NSW, Australia; School of Public Health & Medicine, The University of Newcastle, Callaghan, NSW, Australia
| | - H Hondermarck
- School of Biomedical Sciences & Pharmacy, The University of Newcastle, Callaghan, NSW, Australia; Hunter Medical Research Institute; School of Mathematical and Physical Sciences, The University of Newcastle, Callaghan, NSW, Australia; School of Public Health & Medicine, The University of Newcastle, Callaghan, NSW, Australia
| |
Collapse
|
30
|
Clover K, Rogers K, Britton B, Oldmeadow C, Attia J, Carter G. Reduced prevalence of pain and distress during 4 years of screening with QUICATOUCH in Australian oncology patients. Eur J Cancer Care (Engl) 2017; 26. [DOI: 10.1111/ecc.12636] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2016] [Revised: 11/21/2016] [Accepted: 11/24/2016] [Indexed: 11/26/2022]
Affiliation(s)
- K.A. Clover
- Psycho-Oncology Service; Calvary Mater Newcastle; Hunter Regional Mail Centre NSW Australia
- Centre for Brain and Mental Health Research (CBMHR); University of Newcastle; Callaghan NSW Australia
| | - K.M. Rogers
- Psycho-Oncology Service; Calvary Mater Newcastle; Hunter Regional Mail Centre NSW Australia
| | - B. Britton
- Psycho-Oncology Service; Calvary Mater Newcastle; Hunter Regional Mail Centre NSW Australia
| | - C. Oldmeadow
- Hunter Medical Research Institute; New Lambton Heights NSW Australia
| | - J. Attia
- Hunter Medical Research Institute; New Lambton Heights NSW Australia
- School of Medicine and Public Health; University of Newcastle; Callaghan NSW Australia
- Department of Medicine; John Hunter Hospital; Newcastle NSW Australia
| | - G.L. Carter
- Centre for Brain and Mental Health Research (CBMHR); University of Newcastle; Callaghan NSW Australia
| |
Collapse
|
31
|
Bezivin C, Attia J, De Torsiac M, Loing E. 339 Swertiamarin: a promising new treatment for Rosacea. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.06.359] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Garland J, Tse R, Oldmeadow C, Attia J, Anne S, Cala A. Elevation of post mortem vitreous humour sodium and chloride levels can be used as a reliable test in cases of suspected salt water drowning when the immersion times are less than one hour. Forensic Sci Int 2016; 266:338-342. [DOI: 10.1016/j.forsciint.2016.06.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2016] [Revised: 05/14/2016] [Accepted: 06/03/2016] [Indexed: 10/21/2022]
|
33
|
Khan A, Zhang X, Hu D, Ma X, Ding R, Attia J, Boyle A. Increasing Mortality from Ischaemic Heart Disease in China from 2004 - 2010: 438 Million Person-Years Follow Up. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
34
|
Emami M, Barlow M, Leitch J, Wilsmore B, Mills M, Cambourn M, Meakes S, Davies A, Attia J, Boyle A, Jackson N. Body Mass Index and Ablation for Atrial Fibrillation Predicts Vascular Access Complications in Electrophysiology Procedures. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
35
|
Delahunt B, Egevad L, Srigley JR, Steigler A, Murray JD, Atkinson C, Matthews J, Duchesne G, Spry NA, Christie D, Joseph D, Attia J, Denham JW. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data. Pathology 2016; 47:520-5. [PMID: 26325671 DOI: 10.1097/pat.0000000000000318] [Citation(s) in RCA: 42] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
In 2014 a consensus conference convened by the International Society of Urological Pathology (ISUP) adopted amendments to the criteria for Gleason grading and scoring (GS) for prostatic adenocarcinoma. The meeting defined a modified grading system based on 5 grading categories (grade 1, GS 3+3; grade 2, GS 3+4; grade 3, GS 4+3; grade 4, GS 8; grade 5, GS 9-10). In this study we have evaluated the prognostic significance of ISUP grading in 496 patients enrolled in the TROG 03.04 RADAR Trial. There were 19 grade 1, 118 grade 2, 193 grade 3, 88 grade 4 and 79 grade 5 tumours in the series, with follow-up for a minimum of 6.5 years. On follow-up 76 patients experienced distant progression of disease, 171 prostate specific antigen (PSA) progression and 39 prostate cancer deaths. In contrast to the 2005 modified Gleason system (MGS), the hazards of the distant and PSA progression endpoints, relative to grade 2, were significantly greater for grades 3, 4 and 5 of the 2014 ISUP grading scheme. Comparison of predictive ability utilising Harrell's concordance index, showed 2014 ISUP grading to significantly out-perform 2005 MGS grading for each of the three clinical endpoints.
Collapse
Affiliation(s)
- B Delahunt
- 1Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, Wellington, New Zealand 2Department of Oncology - Pathology, Karolinska Institute, Stockholm, Sweden 3Department of Pathology and Molecular Medicine, McMaster University, Toronto, Canada 4School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia 5St Georges Cancer Care Centre, Christchurch 6Auckland Hospital, Auckland, New Zealand 7Peter MacCallum Cancer Centre, Melbourne, Vic 8Sir Charles Gairdner Hospital, Perth, WA 9Genesis Care, Tugun, Qld 10Hunter Medical Research Institute, Newcastle, NSW, Australia
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Paterson MA, Smart CEM, Lopez PE, McElduff P, Attia J, Morbey C, King BR. Influence of dietary protein on postprandial blood glucose levels in individuals with Type 1 diabetes mellitus using intensive insulin therapy. Diabet Med 2016; 33:592-8. [PMID: 26499756 PMCID: PMC5064639 DOI: 10.1111/dme.13011] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/21/2015] [Indexed: 01/30/2023]
Abstract
AIM To determine the effects of protein alone (independent of fat and carbohydrate) on postprandial glycaemia in individuals with Type 1 diabetes mellitus using intensive insulin therapy. METHODS Participants with Type 1 diabetes mellitus aged 7-40 years consumed six 150 ml whey isolate protein drinks [0 g (control), 12.5, 25, 50, 75 and 100] and two 150 ml glucose drinks (10 and 20 g) without insulin, in randomized order over 8 days, 4 h after the evening meal. Continuous glucose monitoring was used to assess postprandial glycaemia. RESULTS Data were collected from 27 participants. Protein loads of 12.5 and 50 g did not result in significant postprandial glycaemic excursions compared with control (water) throughout the 300 min study period (P > 0.05). Protein loads of 75 and 100 g resulted in lower glycaemic excursions than control in the 60-120 min postprandial interval, but higher excursions in the 180-300 min interval. In comparison with 20 g glucose, the large protein loads resulted in significantly delayed and sustained glucose excursions, commencing at 180 min and continuing to 5 h. CONCLUSIONS Seventy-five grams or more of protein alone significantly increases postprandial glycaemia from 3 to 5 h in people with Type 1 diabetes mellitus using intensive insulin therapy. The glycaemic profiles resulting from high protein loads differ significantly from the excursion from glucose in terms of time to peak glucose and duration of the glycaemic excursion. This research supports recommendations for insulin dosing for large amounts of protein.
Collapse
Affiliation(s)
- M A Paterson
- Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Rankin Park, NSW, Australia
- Faculty of Health, School of Medicine, University of Newcastle, NSW, Australia
| | - C E M Smart
- Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Rankin Park, NSW, Australia
- Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle, NSW, Australia
| | - P E Lopez
- Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Rankin Park, NSW, Australia
- Faculty of Health, School of Medicine, University of Newcastle, NSW, Australia
| | - P McElduff
- Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Rankin Park, NSW, Australia
| | - J Attia
- Hunter Medical Research Institute, School of Medicine and Public Health, University of Newcastle, Rankin Park, NSW, Australia
| | - C Morbey
- Aim Diabetes Management Centre, Newcastle, NSW, Australia
| | - B R King
- Faculty of Health, School of Medicine, University of Newcastle, NSW, Australia
- Department of Paediatric Endocrinology and Diabetes, John Hunter Children's Hospital, Newcastle, NSW, Australia
| |
Collapse
|
37
|
Abstract
SUMMARY We assessed the ability of a fracture liaison service (FLS) to directly reduce re-fracture risk. Having a FLS is associated with a ∼40% reduction in the 3-year risk of major bone and ∼30% of any bone re-fracture. The number needed to treat to prevent a re-fracture is 20. INTRODUCTION FLS have been promoted as the most effective interventions for secondary fracture prevention, and while there is evidence of increased rate of investigation and treatment at institutions with a FLS, only a few studies have considered fracture outcomes directly. We therefore sought to evaluate the ability of our FLS to reduce re-fracture risk. METHODS Historical cohort study of all patients ≥50 years presenting over a 6-month period with a minimal trauma fracture (MTF) to the emergency departments of a tertiary hospital with a FLS, and one without a FLS. Baseline characteristics, mortality and MTFs over a 3-year follow-up were recorded. RESULTS Five hundred fifteen patients at the FLS hospital and 416 patients at the non-FLS hospital were studied. Over 3 years, 63/515 (12%) patients at the FLS hospital and 70/416 (17%) at the non-FLS hospital had a MTF. All patients were analysed in an intention-to-treat analysis regardless of whether they were seen in the FLS follow-up clinic. Statistical analysis using Cox proportional hazard models in the presence of a competing risk of death from any cause was used. After adjustment for baseline characteristics, there was a ∼30% reduction in rate of any re-fracture at the FLS hospital (hazard ratio (HR) 0.67, confidence interval (CI) 0.47-0.95, p value 0.025) and a ∼40% reduction in major re-fractures (hip, spine, femur, pelvis or humerus) (HR 0.59, CI 0.39-0.90, p value 0.013). CONCLUSIONS We found a ∼30% reduction in any re-fractures and a ∼40% reduction in major re-fractures at the FLS hospital compared with a similar non-FLS hospital. The number of patients needed to treat to prevent one new fracture over 3 years is 20.
Collapse
Affiliation(s)
- A Nakayama
- Department of Rheumatology, Bone and Joint Centre Royal Newcastle Centre/John Hunter Hospital, Lookout Road, New Lambton Heights, Newcastle, New South Wales, 2305, Australia
| | - G Major
- Department of Rheumatology, Bone and Joint Centre Royal Newcastle Centre/John Hunter Hospital, Lookout Road, New Lambton Heights, Newcastle, New South Wales, 2305, Australia.
- Faculty of Medicine University of Newcastle, Newcastle, New South Wales, 2308, Australia.
| | - E Holliday
- Faculty of Medicine University of Newcastle, Newcastle, New South Wales, 2308, Australia
- Hunter Medical Research Institute, Newcastle, New South Wales, 2308, Australia
| | - J Attia
- Faculty of Medicine University of Newcastle, Newcastle, New South Wales, 2308, Australia
- Hunter Medical Research Institute, Newcastle, New South Wales, 2308, Australia
| | - N Bogduk
- Department of Rheumatology, Bone and Joint Centre Royal Newcastle Centre/John Hunter Hospital, Lookout Road, New Lambton Heights, Newcastle, New South Wales, 2305, Australia
- Faculty of Medicine University of Newcastle, Newcastle, New South Wales, 2308, Australia
| |
Collapse
|
38
|
Abdullah N, Abdul Murad NA, Attia J, Oldmeadow C, Mohd Haniff EA, Syafruddin SE, Abd Jalal N, Ismail N, Ishak M, Jamal R, Scott RJ, Holliday EG. Characterizing the genetic risk for Type 2 diabetes in a Malaysian multi-ethnic cohort. Diabet Med 2015; 32:1377-84. [PMID: 25711284 DOI: 10.1111/dme.12735] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2014] [Revised: 12/03/2014] [Accepted: 02/20/2015] [Indexed: 12/12/2022]
Abstract
AIMS To characterize the association with Type 2 diabetes of known Type 2 diabetes risk variants in people in Malaysia of Malay, Chinese and Indian ancestry who participated in the Malaysian Cohort project. METHODS We genotyped 1604 people of Malay ancestry (722 cases, 882 controls), 1654 of Chinese ancestry (819 cases, 835 controls) and 1728 of Indian ancestry (851 cases, 877 controls). First, 62 candidate single-nucleotide polymorphisms previously associated with Type 2 diabetes were assessed for association via logistic regression within ancestral groups and then across ancestral groups using a meta-analysis. Second, estimated odds ratios were assessed for excess directional concordance with previously studied populations. Third, a genetic risk score aggregating allele dosage across the candidate single-nucleotide polymorphisms was tested for association within and across ancestral groups. RESULTS After Bonferroni correction, seven individual single-nucleotide polymorphisms were associated with Type 2 diabetes in the combined Malaysian sample. We observed a highly significant excess in concordance of effect directions between Malaysian and previously studied populations. The genetic risk score was strongly associated with Type 2 diabetes in all Malaysian groups, explaining from 1.0 to 1.7% of total Type 2 diabetes risk variance. CONCLUSION This study suggests there is substantial overlap of the genetic risk alleles underlying Type 2 diabetes in Malaysian and other populations.
Collapse
Affiliation(s)
- N Abdullah
- School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - N A Abdul Murad
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - J Attia
- Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
- Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia
| | - C Oldmeadow
- Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
- Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia
| | - E A Mohd Haniff
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - S E Syafruddin
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - N Abd Jalal
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - N Ismail
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - M Ishak
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - R Jamal
- UKM Medical Molecular Biology Institute, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia
| | - R J Scott
- School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia
- Hunter Area Pathology Service, John Hunter Hospital, Newcastle, New South Wales, Australia
| | - E G Holliday
- Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
- Centre for Clinical Epidemiology and Biostatistics, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia
| |
Collapse
|
39
|
Iseme R, McEvoy M, Kelly B, Agnew L, Attia J, Walker F, Oldmeadow C, Boyle M. Autoantibodies are not Predictive Markers for the Development of Depressive Symptoms in a Population-Based Cohort of Older Adults. Eur Psychiatry 2015; 30:694-700. [DOI: 10.1016/j.eurpsy.2015.06.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/28/2015] [Revised: 06/17/2015] [Accepted: 06/17/2015] [Indexed: 10/23/2022] Open
Abstract
AbstractBackgroundAutoantibodies have been implicated in the etiologic pathway of depressive disorders. Here, we determine the association between the presence of a panel of autoantibodies at baseline and change in depression symptom score over 5-year follow-up in a cohort of healthy elderly Australians.MethodsSerum samples from 2049 randomly selected subjects enrolled in the Hunter Community Study (HCS) aged 55–85 years were assayed for a range of autoimmune markers (anti-nuclear autoantibodies, extractable nuclear antigen autoantibodies, anti-neutrophil cytoplasmic autoantibodies, thyroid peroxidase autoantibodies, tissue transglutaminase autoantibodies, anti-cardiolipin autoantibodies, rheumatoid factor and cyclic citrullinated peptide autoantibodies) at baseline. Depression symptom score was assessed using the Centre for Epidemiological Study (CES-D) scale at baseline and 5 years later.ResultsAutoantibody prevalence varied amongst our sample with ANA being the most prevalent; positive in 16% and borderline in 36% of study population. No evidence for a relationship was found between change in CES-D score over time and any autoimmune marker. Statins and high cholesterol were significantly associated with change in CES-D score over time in univariate analysis; however, these were probably confounded since they failed to remain significant following multivariable analysis.ConclusionsAutoantibodies were not associated with change in CES-D score over time. These findings point to an absence of autoimmune mechanisms in the general population or in moderate cases of depression.
Collapse
|
40
|
Bezivin C, Pérolat A, Attia J, Loing E. Communication cellulaire entre cellules souches adipocytaires et kératinocytes : une nouvelle stratégie pour la régénération épidermique. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.04.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
41
|
Thomas L, Levi C, Attia J, Rivett D. Recognition of patients presenting with or at risk of craniocervical arterial dissection: preliminary results of a prospective study. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.1497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
42
|
Khan A, Agahari I, Ashraf A, Attia J. Assessment of junior medical staff's ability to diagnose ST Elevation Myocardial Infarction (STEMI) on ECG in a level 3 teaching hospital in Australia. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
43
|
Abstract
There is a high rate of mortality in elderly
patients who sustain a fracture of the hip. We aimed to determine
the rate of preventable mortality and errors during the management
of these patients. A 12 month prospective study was performed on
patients aged > 65 years who had sustained a fracture of the hip.
This was conducted at a Level 1 Trauma Centre with no orthogeriatric
service. A multidisciplinary review of the medical records by four
specialists was performed to analyse errors of management and elements
of preventable mortality. During 2011, there were 437 patients aged
> 65 years admitted with a fracture of the hip (85 years (66 to
99)) and 20 died while in hospital (86.3 years (67 to 96)). A total
of 152 errors were identified in the 80 individual reviews of the
20 deaths. A total of 99 errors (65%) were thought to have at least
a moderate effect on death; 45 reviews considering death (57%) were thought
to have potentially been preventable. Agreement between the panel
of reviewers on the preventability of death was fair. A larger-scale
assessment of preventable mortality in elderly patients who sustain
a fracture of the hip is required. Multidisciplinary review panels
could be considered as part of the quality assurance process in
the management of these patients. Cite this article: Bone Joint J 2014;96-B:1178–84.
Collapse
Affiliation(s)
- S M Tarrant
- John Hunter Hospital, Newcastle, University of Newcastle, Department of Traumatology, John Hunter Hospital and University of Newcastle, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW, 2310, Australia
| | - B M Hardy
- John Hunter Hospital, Newcastle, University of Newcastle, Department of Traumatology, John Hunter Hospital and University of Newcastle, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW, 2310, Australia
| | - P L Byth
- John Hunter Hospital, Newcastle, University of Newcastle, Department of Traumatology, John Hunter Hospital and University of Newcastle, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW, 2310, Australia
| | - T L Brown
- John Hunter Hospital, Newcastle, University of Newcastle, Department of Traumatology, John Hunter Hospital and University of Newcastle, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW, 2310, Australia
| | - J Attia
- John Hunter Hospital, Newcastle, University of Newcastle, Department of Traumatology, John Hunter Hospital and University of Newcastle, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW, 2310, Australia
| | - Z J Balogh
- John Hunter Hospital, Newcastle, University of Newcastle, Department of Traumatology, John Hunter Hospital and University of Newcastle, Locked Bag 1, Hunter Region Mail Centre, Newcastle, NSW, 2310, Australia
| |
Collapse
|
44
|
Abstract
BACKGROUND Many students find the peripheral sensory examination confusing. We set out to summarise the evidence base in order to provide guidance on the most useful manoeuvres. METHODS We performed a literature review starting with 5 secondary sources, supplemented by a literature search on MEDLINE. RESULTS A useful approach to neuropathy is to divide these into large fibre sensory neuropathy (LFSN) in which vibration and proprioception are affected, and small fibre sensory neuropathy (SFSN) in which pain and temperature are affected. Positive sensory symptoms such as burning, electric or sunburn pain point to a SFSN; negative symptoms such as loss of sensation, numbness or deep pain point to a LFSN. If LFSN is suspected, the most reproducible and best studied physical examination is a 10 g monofilament, but vibration sense is also useful. There is much less data on the best physical examination for a SFSN. The most appropriate diagnostic test for SFSN is quantitative sensory testing, whereas for LFSN a nerve conduction study is indicated. CONCLUSIONS A modest amount of evidence is available to guide peripheral sensory examination but more research is needed.
Collapse
Affiliation(s)
- D Williams
- Division of Medicine, John Hunter Hospital, Hunter New England Local Health District, Newcastle, NSW, Australia
| | | | | | | |
Collapse
|
45
|
Jackel D, Attia J, Pickles R. General medicine advanced training: lessons from the John Hunter training programme. Intern Med J 2014; 44:302-6. [DOI: 10.1111/imj.12357] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2013] [Accepted: 12/17/2013] [Indexed: 11/27/2022]
Affiliation(s)
- D. Jackel
- Division of Medicine; John Hunter Hospital; Newcastle New South Wales Australia
| | - J. Attia
- Division of Medicine; John Hunter Hospital; Newcastle New South Wales Australia
- School of Medicine and Public Health; University of Newcastle; Newcastle New South Wales Australia
- Hunter Medical Research Institute; Newcastle New South Wales Australia
| | - R. Pickles
- Division of Medicine; John Hunter Hospital; Newcastle New South Wales Australia
- School of Medicine and Public Health; University of Newcastle; Newcastle New South Wales Australia
| |
Collapse
|
46
|
Numthavaj P, Tanjararak K, Roongpuvapaht B, McEvoy M, Attia J, Thakkinstian A. Efficacy of Mitomycin C for postoperative endoscopic sinus surgery: a systematic review and meta-analysis. Clin Otolaryngol 2013; 38:198-207. [DOI: 10.1111/coa.12114] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/26/2013] [Indexed: 11/28/2022]
Affiliation(s)
| | - K. Tanjararak
- Department of Otolaryngology; Faculty of Medicine; Ramathibodi Hospital; Mahidol University; Bangkok; Thailand
| | - B. Roongpuvapaht
- Department of Otolaryngology; Faculty of Medicine; Ramathibodi Hospital; Mahidol University; Bangkok; Thailand
| | - M. McEvoy
- Centre for Clinical Epidemiology and Biostatistics; The University of Newcastle; Newcastle; NSW; Australia
| | - J. Attia
- Centre for Clinical Epidemiology and Biostatistics; The University of Newcastle; Newcastle; NSW; Australia
| | - A. Thakkinstian
- Section for Clinical Epidemiology and Biostatistics; Faculty of Medicine, Ramathibodi Hospital; Mahidol University; Bangkok; Thailand
| |
Collapse
|
47
|
Hiles SA, Baker AL, de Malmanche T, Attia J. Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychol Med 2012; 42:2015-2026. [PMID: 22336436 DOI: 10.1017/s0033291712000128] [Citation(s) in RCA: 161] [Impact Index Per Article: 13.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND Cross-sectional studies support an association between depression and inflammatory markers. However, little is known of their relationship in the context of antidepressant treatment. Our aim was to explore via meta-analysis whether antidepressant treatment is associated with a reduction in three inflammatory markers associated with depression. METHOD A computerized search of EMBASE, Medline, PsycINFO and Cochrane Library databases was completed using subject headings for depression and either interleukin-6, C-reactive protein or interleukin-10, selecting studies which reported circulating levels of inflammatory markers before and after antidepressant treatment for people with depression. Outcome and moderator variables were coded for analysis, including inflammatory marker change, depression severity change, age, gender ratio, assay brand, treatment response and weight change. RESULTS Pooled effect sizes showed a significant decrease in interleukin-6 (n=14, d=-0.42, p=0.02), marginally significant decrease in C-reactive protein (n=8, d=-0.57, p=0.05) and a non-significant decrease in interleukin-10 (n=3, d=-0.45, p=0.14) after treatment. High levels of heterogeneity were observed, which may be associated with clinical variations between the studies such as weight gain, anxiety, incomplete remission and other individual differences and co-morbidities. CONCLUSIONS The findings of this meta-analysis indicate that there may be a normalization of overactive inflammatory processes following antidepressant treatment.
Collapse
Affiliation(s)
- S A Hiles
- Centre for Brain and Mental Health Research, Faculty of Health, University of Newcastle, New South Wales, Australia.
| | | | | | | |
Collapse
|
48
|
Wilasrusmee C, Sukrat B, McEvoy M, Attia J, Thakkinstian A. Systematic review and meta-analysis of safety of laparoscopic versus open appendicectomy for suspected appendicitis in pregnancy. Br J Surg 2012; 99:1470-8. [PMID: 23001791 PMCID: PMC3494303 DOI: 10.1002/bjs.8889] [Citation(s) in RCA: 119] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/14/2012] [Indexed: 12/12/2022]
Abstract
BACKGROUND Laparoscopic appendicectomy has gained wide acceptance as an alternative to open appendicectomy during pregnancy. However, data regarding the safety and optimal surgical approach to appendicitis in pregnancy are still controversial. METHODS This was a systematic review and meta-analysis of studies comparing laparoscopic and open appendicectomy in pregnancy identified using PubMed and Scopus search engines from January 1990 to July 2011. Two reviewers independently extracted data on fetal loss, preterm delivery, wound infection, duration of operation, hospital stay, Apgar score and birth weight between laparoscopic and open appendicectomy groups. RESULTS Eleven studies with a total of 3415 women (599 in laparoscopic and 2816 in open group) were included in the analysis. Fetal loss was statistically significantly worse in those who underwent laparoscopy compared with open appendicectomy; the pooled relative risk (RR) was 1·91 (95 per cent confidence interval (c.i.) 1·31 to 2·77) without heterogeneity. The pooled RR for preterm labour was 1·44 (0·68 to 3·06), but this risk was not statistically significant. The mean difference in length of hospital stay was - 0·49 (-1·76 to - 0·78) days, but this was not clinically significant. No significant difference was found for wound infection, birth weight, duration of operation or Apgar score. CONCLUSION The available low-grade evidence suggests that laparoscopic appendicectomy in pregnant women might be associated with a greater risk of fetal loss.
Collapse
Affiliation(s)
- C Wilasrusmee
- Department of Surgery, Section for Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
| | | | | | | | | |
Collapse
|
49
|
Siribumrungwong B, Noorit P, Wilasrusmee C, Attia J, Thakkinstian A. A Systematic Review and Meta-analysis of Randomised Controlled Trials Comparing Endovenous Ablation and Surgical Intervention in Patients with Varicose Vein. Eur J Vasc Endovasc Surg 2012; 44:214-23. [PMID: 22705163 DOI: 10.1016/j.ejvs.2012.05.017] [Citation(s) in RCA: 125] [Impact Index Per Article: 10.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2012] [Accepted: 05/17/2012] [Indexed: 11/30/2022]
|
50
|
Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae F, Attia J, McEvoy M. Current state of medical-advice-seeking behaviour for symptoms of colorectal cancer: determinants of failure and delay in medical consultation. Colorectal Dis 2012; 14:e222-9. [PMID: 22381146 DOI: 10.1111/j.1463-1318.2012.02881.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
AIM There are few data on the factors associated with healthcare-seeking behaviour for symptoms of colorectal cancer. This study describes the determinants of failure and delay in seeking medical advice for rectal bleeding and change in bowel habit. METHOD In total, 1592 persons (56-88 years) were randomly selected from the Hunter Community Study and mailed a questionnaire. RESULTS In all, 18% (60/332) of respondents experiencing rectal bleeding and 20% (39/195) reporting change in bowel habit had never consulted a doctor. The rate of delay (>1 month) for each symptom was 18% and 37%. The reasons for delay included the assumption that the symptoms were not serious or that they were benign. Triggers for seeking medical advice varied. Healthcare-seeking behaviour for rectal bleeding had not significantly improved compared with a previous community-based study. CONCLUSION The seriousness of symptoms, importance of early detection and prompt medical consultation must be articulated in health messages to at-risk persons.
Collapse
Affiliation(s)
- R J Courtney
- Priority Research Centre for Health Behaviour, School of Medicine and Public Health, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia.
| | | | | | | | | | | |
Collapse
|